Fella Health offers a tailored and holistic approach by combining personalized GLP-1 medication plans with behavioral support and coaching to promote sustainable weight loss
11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of the two highest investigational doses of retatrutide, a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity
Contact your GP urgently if you experience blood in urine, severe pain, fever, inability to pass urine, or significantly reduced urine output
Testicular vascular cone development and its association with scrotal thermoregulation, semen quality and sperm production in bulls